Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs (India) Ltd

NSE: KILITCH

BSE: 524500

Small Cap

Pharma Sector

₹181.71

-1.71

(-0.93%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Kilitch Drugs (India) Stock Performance

as on June 11, 2026 at 8:03 pm IST

  • Day's Low

    Day's High

    ₹179.27
    ₹189.50
    downward going graph

    1.34%

    Downside

    4.29%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹117.25
    ₹250.00
    downward going graph

    35.47%

    Downside

    37.58%

    Upside

    downward going graph

Kilitch Drugs (India) share price movements today

Previous Close
₹183.42
Open
₹180.67
Volume
1.12L
Upper Circuit
₹220.10
Lower Circuit
₹146.74
Day's Low - High
₹179.27 - ₹189.50
52 Week Low - High
₹117.25 - ₹250.00

Kilitch Drugs (India) Historical Returns

1 Month Return
+ 16.17 %
3 Month Return
-42.3 %
1 Year Return
-59.69 %
3 Year Return
-8.77 %
5 Year Return
+ 13.89 %

Kilitch Drugs (India) Fundamentals

as on June 11, 2026 at 2:33 pm IST

Market Cap

₹641.27 Cr

Return on Equity (ROE)

11.02

PE Ratio (TTM)

20.62

Return on capital employed (ROCE)

13.14

Industry PE ratio

46.39

Beta (LTM)

1

P/B Ratio

2.3

Dividend Yield

0

PEG Ratio

23.3

Quarterly Earnings Growth YOY

45.6

EPS (TTM)

7.58913935930244

Book Value

61.56

Kilitch Drugs (India) Stock Valuation

as on June 11, 2026 at 2:33 pm IST

Kilitch Drugs (India) in the last 5 years

  • Overview

  • Trends

Lowest (-986.00x)

July 3, 2019

Today (20.62x)

June 10, 2026

Industry (46.39x)

June 10, 2026

Highest (371.68x)

October 16, 2020

LowHigh

Today’s Price to Earnings Ratio: 20.62x

Kilitch Drugs (India) Technical Analysis

Track how Kilitch Drugs (India) technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish11
Bullish1
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.06
Bearish
CCI (20)
-95.15
Neutral
RSI (14)
42.36
Neutral
Momentum (10)
-0.7
Neutral
ADI (14)
30.53
Bearish
Ultimate Oscillator (7,14,28)
17.19
Bearish

Moving Averages

Name

Value

Action

SMA (20)
181.39
Bearish
EMA (20)
181.25
Bearish
VWMA (20)
181.39
Bearish
SMA (50)
181.06
Bearish
EMA (50)
181.1
Bearish
SMA (200)
181.86
Bearish
EMA (200)
181.83
Bearish
KAMA (200)
181.01
Bearish
DEMA (200)
180.57
Bullish

Kilitch Drugs (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs (India) with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
NA641.272.78%0.6024198
Nectar Lifescience Ltd image
Nectar Lifescience Ltd
NA223.59-14.31%0.69-1141,669
Deep Health AI India Ltd image
Deep Health AI India Ltd
NA30.2717.17%0.5111
Fredun Pharmaceuticals Ltd image
Fredun Pharmaceuticals Ltd
NA1,280.7189.04%0.7719453
Samrat Pharmachem Ltd image
Samrat Pharmachem Ltd
NA63.34-3.23%0.007285
See all

Kilitch Drugs (India) Stock’s Investor Sentiment and Interest

Search interest for Kilitch Drugs (India) Ltd Stock has increased by 93% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:93% versus previous 30 day period

Kilitch Drugs (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
36.56
41.2
31.79
44.82
33.45
47.47
56.17
61.23
43.14
48.92
53.81
89.6
Other Income
0.56
0.49
2.96
0.47
2.57
5.16
1.73
1.7
2.56
6.66
1.53
0.49
Total Income
37.12
41.69
34.75
45.29
36.03
52.64
57.89
62.92
45.7
55.58
55.34
90.1
Expenses
30.38
32.58
29.51
37.74
31.79
41.38
47.43
46.63
39.88
43.88
47.66
67.46
Operating Profit
6.18
8.62
2.28
7.08
1.66
6.09
8.74
14.6
3.26
5.04
6.15
22.14
Operating Profit Margin %
16.9%
20.92%
7.17%
15.8%
4.96%
12.83%
15.56%
23.84%
7.56%
10.3%
11.43%
24.71%
Profit Before Interest, Tax and Depreciation
6.74
9.11
5.24
7.55
4.23
11.26
10.46
16.29
5.82
11.7
7.68
22.64
Interest
1.5
1.51
1.6
1.32
1.73
0.31
1.4
1.6
1.53
1.44
1.15
1.44
Depreciation
0.71
0.82
0.81
0.93
0.85
0.61
0.81
0.85
0.84
0.86
0.94
0.98
Profit Before Tax
4.53
6.78
2.83
5.3
1.65
10.34
8.25
13.84
3.45
9.4
5.59
20.22
Tax Paid
1.48
1.69
1.08
1.62
1.54
1.73
2.64
3.63
1.19
1.36
1.28
5.33
Profit After Tax
3.06
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
4.32
14.88
Total Net profit including share of profit / Loss from associate company
3.06
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
4.32
14.88
EPS
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
Actual EPS
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
Adjusted EPS
1.05
1.43
0.91
1.1
0.41
2.62
1.82
3.17
0.92
2.49
1.25
4.24
Diluted EPS
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24

Kilitch Drugs (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
51.01
82.49
53.32
68.52
114.23
139.6
154.37
198.32
235.47
Other Income
2.88
4
4.13
2.67
2.91
2.92
4.48
11.16
11.24
Total Income
53.89
86.49
57.45
71.19
117.14
142.52
158.85
209.48
246.71
Expenses
45.73
75.48
53.12
63.33
103.87
122.03
130.22
166.85
198.88
Operating Profit
5.28
7.01
0.2
5.19
10.36
17.57
24.15
31.47
36.59
Operating Profit Margin %
10.35%
8.5%
0.38%
7.57%
9.07%
12.59%
15.64%
15.87%
15.54%
Profit Before Interest, Tax and Depreciation
8.16
11.02
4.32
7.86
13.28
20.48
28.63
42.63
47.84
Interest
-
0.38
0.72
0.75
1.2
4.92
5.93
5.04
5.56
Depreciation
2.04
2.05
2
1.99
2.47
3.55
3.35
3.11
3.62
Profit Before Tax
6.12
8.59
1.6
5.12
9.61
12.01
19.35
34.48
38.66
Tax Paid
0.96
4.76
0.77
1.36
3.4
3.73
5.78
9.53
9.16
Profit After Tax
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
29.5
Total Net profit including share of profit / Loss from associate company
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
29.5
EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91
Actual EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91
Adjusted EPS
1.9
1.28
0.27
1.16
2.31
3.28
4.49
8.12
8.91
Diluted EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91

Kilitch Drugs (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.23
1.12
1.42
0.29
4.46
45.66
5.78
2.59
-1.53
17.54
Cash Flow from Investing Activities
23.49
-1.54
-4.45
-13.98
-10.46
-37.57
-15.25
7.91
-8.15
-39.94
Cash Flow from Financing Activities
0.12
-0.04
5.51
16.85
0.85
1.61
7.03
-0.72
8.81
13.25
Net Cash Flow
-2.23
-0.45
2.48
3.17
-5.14
9.7
-2.44
9.78
-0.88
-9.16

Kilitch Drugs (India) Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
63.77%
63.77%
63.77%
Public
30.77%
30.77%
30.77%
30.77%
30.76%
30.77%
30.77%
30.76%
36.23%
36.23%
36.22%
Total Outstanding Shares
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,74,80,782
1,74,80,782
3,49,61,564
Total Shareholders
9,002
9,062
9,525
9,620
9,920
10,139
9,749
10,379
10,929
12,043
11,785

Kilitch Drugs (India) Corporate Actions

View detailed summary of the earnings and dividend history of Kilitch Drugs (India).

  • Kilitch Drugs (India) Ltd Earnings Results

    Kilitch Drugs (India) Ltd’s net profit jumped 39.62% since last year same period to ₹14.52Cr in the Q4 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 227.77% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Kilitch Drugs (India) Ltd Dividends May,2019

    In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.27%.

    Read More about Dividends

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 4.43 Cr → 14.52 Cr (in ₹), with an average increase of 69.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, KILITCH stock has moved up by 16.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 55.34 Cr → 90.1 Cr (in ₹), with an average increase of 38.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 147.1% return, outperforming this stock by 155.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.77% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.2% return, outperforming this stock by 98.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 36.23% to 36.22% in Mar 2026 quarter

About Kilitch Drugs (India) Ltd

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Revenue: ₹89.60Cr as on March 2026 (Q4 FY26)
Net Profit: ₹14.88Cr as on March 2026 (Q4 FY26)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMukund P Mehta
E-voting on sharesClick here to vote

FAQs

What is Kilitch Drugs (India) share price today?

Kilitch Drugs (India) share price today stands at ₹181.71 as on . Kilitch Drugs (India) share today touched a day high of ₹189.5 and a low of ₹179.27.

What is the 52 week high and 52 week low range for Kilitch Drugs (India) share?

Kilitch Drugs (India) touched a 52 week high of ₹250 and a 52 week low of ₹117.25. Kilitch Drugs (India) share price today i.e. is trending at ₹181.71, which is -27.32% down from its 52 week high and 54.98% up from its 52 week low.

What is Kilitch Drugs (India)'s market capitalisation today?

Kilitch Drugs (India) market capitalisation is ₹641.27 Cr as on .

How to buy Kilitch Drugs (India) shares?

To buy Kilitch Drugs (India) shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KILITCH or Kilitch Drugs (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kilitch Drugs (India) shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kilitch Drugs (India) trading volume today?

Kilitch Drugs (India) trading volume is 1.12L as on . This means that 1.12L shares of Kilitch Drugs (India) were bought and sold on the stock market during today's trading session.